+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Toxicity of phorbol myristate acetate-stimulated polymorphonuclear neutrophils against rat hepatocytes. Demonstration and mechanism



Toxicity of phorbol myristate acetate-stimulated polymorphonuclear neutrophils against rat hepatocytes. Demonstration and mechanism



Laboratory Investigation; a Journal of Technical Methods and Pathology 59(6): 831-837



Human polymorphonuclear neutrophils (PMN), when exposed to soluble or particulate stimuli, can destroy various types of cells. The purpose of the present work was to investigate the toxicity of phorbol myristate acetate (PMA)-stimulated PMN against hepatocytes. Neutrophils were incubated in basal conditions or after stimulation by 100 ng/ml PMA in the presence of rat hepatocytes isolated by collagenase digestion. Cytotoxicity was quantified by the percentage of alanine aminotransferase (ALAT) activity released by hepatocytes in the culture medium. Whereas unstimulated PMN had only minor effects, PMA-stimulated PMN induced, after a 16-hour incubation, a 29.5% ALAT activity release at a PMN/hepatocyte ratio of 20/1. At the same ratio, stimulated PMN induced a 1.5% and a 16.6% ALAT activity release at 1 and 4 hours, respectively. At 1 hour, electron microscopy showed intimate contacts between PMN and hepatocytes; hepatocytes appeared morphologically normal. Hepatocytic lesions were moderate at 4 hours and marked at 16 hours. Neutrophil-induced hepatocyte toxicity could not be explained by the production of reactive oxygen intermediates since: (a) hepatocyte toxicity was not prevented by either superoxide dismutase or by catalase; (b) PMN obtained from a subject with chronic granulomatous disease were as toxic as PMN obtained from a normal subject. By contrast, a proteinase-mediated mechanism could be implicated since: (a) the supernatant of stimulated PMN induced a 45.9% ALAT activity release, after 16 hours of incubation; (b) three neutral proteinase inhibitors (i.e., alpha 1-proteinase inhibitor, phenylmethylsulfonylfluoride, soybean trypsin inhibitor) as well as fetal calf serum decreased this toxic effect by 82, 86, 81 and 70%, respectively. These inhibitors had no or minor protective effect on the toxicity of stimulated PMN coincubated with hepatocytes. This could be explained by the existence of intimate contacts between PMN and hepatocytes impeding the action of antiproteinases. Our results suggest that PMA-stimulated PMN can damage hepatocytes through the release of proteinases and that the existence of close contacts between PMN and hepatocytes might play a major role in this toxic effect.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041826278

Download citation: RISBibTeXText

PMID: 2848980


Related references

Mechanism of CD11b down-regulation from phorbol myristate acetate stimulated polymorphonuclear neutrophils. Saudi Medical Journal 26(10): 1596-1601, 2005

Phorbol myristate acetate stimulated polymorphonuclears toxicity against hepatocytes evidence for a protease mediated mechanism. Hepatology: 1210, 1986

Phorbol myristate acetate receptors in human polymorphonuclear neutrophils. Journal of Immunology 135(5): 3439-3447, 1985

Dissimilarities in superoxide anion production by human neutrophils stimulated by phorbol myristate acetate or phorbol dibutyrate. Immunopharmacology 19(1): 23-32, 1990

Phorbol myristate acetate induction of chemotactic migration of human polymorphonuclear neutrophils. Inflammation. 17(4): 521-530, 1993

N -AcetylbenzidineDna Adduct Formation by Phorbol 12-Myristate-Stimulated Human Polymorphonuclear Neutrophils. Chemical Research in Toxicology 13(8): 785-792, 2000

N-Acetylbenzidine-DNA adduct formation by phorbol 12-myristate-stimulated human polymorphonuclear neutrophils. Chemical Research in Toxicology 13(8): 785-792, 2000

31 P NMR spectroscopy of phorbol-myristate-acetate stimulated polymorphonuclear human leukocytes. Febs Letters 129(1): 105-108, 1981

Effect on phorbol myristate acetate on normal and chronic granulomatous disease polymorphonuclear neutrophils. Texas Reports on Biology & Medicine 32(3/4): 825-826, 1974

Phosphorus 31 nmr spectroscopy of phorbol myristate acetate stimulated polymorphonuclear human leukocytes. S Letters: 105-108, 1981

NAD(P)H oxidase activity in human neutrophils stimulated by phorbol myristate acetate. Journal of Clinical Investigation 66(6): 1409-1418, 1980

Reciprocal effects between opioid peptides and human polymorphonuclear leukocytes--I. Chemical modifications of Leu-enkephalin by phorbol myristate acetate-stimulated polymorphonuclear leukocytes. Biochemical Pharmacology 43(3): 497-502, 1992

The potassium requirement for phorbol 12 myristate 13 acetate stimulated oxygen consumption by neutrophils. Periodicum Biologorum 83(2): 235-238, 1981

Oxidative mechanisms of escherichia coli destruction by phorbol myristate acetate stimulated neutrophils. Journal of Dental Research 63(SPEC ISSUE): 247, 1984

Studies on nitric oxide free radicals generated from polymorphonuclear leukocytes (PMN) stimulated by phorbol myristate acetate (PMA). Cell Biology International 20(5): 343-350, 1996